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ABSTRACT
LINDY LIU
An Analysis of Household-reported Health Status and Socio-demographic Characteristics
Associated with Adolescent Influenza Vaccination Rates in the United States: 2008 National
Immunization Survey- Teen
(Under the direction of Christine Stauber, Faculty Member)
Background: Influenza is a highly contagious but preventable acute respiratory illness
associated with high morbidity. Seasonal influenza affects approximately 20% to 40% of
children and adolescents. Annual influenza vaccination is an effective approach to prevent illness
but recent studies suggests that adolescents are underutilizing important preventive health
services and that influenza vaccination coverage in high risk adolescents is also suboptimal. The
purpose of this study was to examine the association between household reported health status
and socio-demographic characteristics of U.S. adolescents who reported receiving an influenza
vaccination.
Methods: Data from the 2008 National Immunization Survey were assessed examining various
demographic and socioeconomic characteristics, as well as reported health status of noninstitutionalized adolescents in the U.S. The sample was limited adolescents aged 13-17. Odds
ratios were calculated and multivariate logistic regression was conducted. P-values of < 0.05 and
95% confidence intervals were used to determine statistical significance.
Results: There were 29063 total observations with 18.9% reporting receiving the influenza
vaccine. The results of this study indicate that sex, race and ethnicity, poverty status, health
insurance status, asthma status, having an underlying health condition, missed school days due to
illness or injury, and maternal age are associated with getting immunized against influenza. As
one might expect those who reported having health insurance, having asthma, and having an
underlying health condition had higher likelihood of vaccine. Interestingly, non-Hispanic other
race and multi-race teens in the study were the most likely to receive the influenza vaccine
compared with non-Hispanic white teens.
Conclusions: This study further examines the impact of socio-demographic disparities and
health status on influenza vaccination coverage. Although the current influenza vaccine
recommendations now include all individuals ages 6 months and older, it should still be
important to recognize disparities and inequalities which contribute to non-vaccination or undervaccination. Improved understanding of demographic and socioeconomic characteristics, as well
as existing underlying health conditions, will facilitate the path to improving interventions,
vaccination rates, and subsequent reduction in the burden of this preventable disease.
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CHAPTER I
INTRODUCTION

1.1 Background
Influenza is a preventable and highly contagious viral acute respiratory disease of
global importance that has caused pandemics of human disease for centuries [1-2]. The
World Health Organization (WHO) estimates that 3 to 5 million case of severe illness and
250,000 to 500,000 deaths worldwide are attributed to influenza, and that the direct and
indirect costs of influenza in industrialized countries are approximately 10-60 million
United States Dollars per million persons per season [3-4]. Although the severity of an
influenza season can vary substantially each year, approximately 200,000 hospitalizations
and 23,000 deaths are caused by influenza in a typical endemic season in the United
States [5-7].
People of all ages are afflicted, but the pediatric burden is considerable and the
prevalence is greatest in school-age children [7-8]. Approximately 20% to 40% of
children and adolescents are affected by influenza each year [9]. In children with highrisk health conditions, the disease accounts for 2 to 4 times higher rates of
hospitalizations, 120 to 200 outpatient visits, and 65-140 antibiotic courses per 1000
children per year [10]. Although influenza-associated pediatric mortality is rare and
children with risk factors for influenza complications are at highest risk for death, many
influenza infections are not diagnosed clinically and the majority of pediatric deaths have
occurred among previously healthy children without any known high-risk conditions
1

[11-12]. In addition, recent studies have shown an increase in bacterial co-infections in
influenza-associated pediatric cases where children were significantly older and more
likely to have pneumonia [11].
Annual influenza vaccination is the most effective strategy for preventing infection
and decreasing transmission within communities [13]. Routine vaccination of children,
health-care professionals, and other individuals who could serve as a source of influenza
virus transmission provides additional protection to persons at risk for influenza
complications and reduces the overall influenza burden [13]. High vaccination coverage
in school-aged children not only provides indirect protection to families, unimmunized
classmates, and school staff, but it may also benefit schools by reducing student and
teacher absenteeism [14].
Although seasonal influenza is the most common cause of vaccine-preventable death
in the Unites States, vaccination rates remain low for all categories of people at highest
risk [15-16]. Despite the burden of disease, the development of safe and effective
vaccines, and long-standing vaccination recommendations by the Advisory Committee on
Immunization Practices (ACIP), studies have revealed that influenza vaccination
coverage among children and adolescents with high-risk conditions ranges only from 9%
to 31% [15, 17]. Although there are many vaccine mandates for the pediatric population
in the United States, there are no known influenza vaccination mandates for students
enrolled in school or day care. Currently, requirements only exist in long-term care
facilities in select states [18]. Even with vaccine recommendations and public service
announcements that explain the benefits of vaccines, there remains a subset of the
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population who declines vaccinations because of religious beliefs, personal preferences,
and freedom of choice [19].
1.2 Purpose of Study
Influenza illness severity, mortality, healthcare costs, and productivity losses are
greatest in high-risk groups, but cost and lost productivity among non-high-risk groups
are also considerable [20]. Adolescent youth are an active and collective group, and play
an important role in the spread of disease, but studies suggest that adolescents do not
access health care regularly despite recommendations for annual health care-visits [2122]. Strategies and programs to reduce missed opportunities in physicians’ offices to
improve vaccine coverage have had limited success [14].
Substantial disparities attributed to demographic and socio-economic status exists in
the receipt of annual influenza vaccination, and interventions do not cover those who do
not seek regular medical care or those who are not insured [23]. Secondly, mothers are
often strongly influential in the vaccination of their children and assume primary
responsibility for their children’s preventive health services [24]. If adolescents are
underutilizing important preventive health services, and if influenza vaccination coverage
in high-risk adolescents is suboptimal, it is important to examine and characterize this
population to increase coverage. Therefore an understanding of the socio-demographic
characteristics, including maternal socio-demographic characteristics, as well as
household-reported health status in adolescents may provide opportunity for targeted
approaches to reduce the health disparities for influenza vaccination and ultimately the
burden of disease.
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1.3 Research Question
To further investigate predictors of why adolescents aged 13 to 17 in the 2008
National Immunization Survey- Teen receive the influenza vaccine, the following
questions will be examined:
1. What are the demographic characteristics of adolescents who receive influenza
vaccinations?
2. What are the socioeconomic characteristics of adolescents who receive influenza
vaccinations?
3. What are the household-reported health status of adolescents who receive
influenza vaccinations?
4. What are the maternal socio-demographic characteristics of adolescents who
receive influenza vaccinations?
5. Do the typical trends of social determinants of health also apply to influenza
vaccination trends?
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Chapter II

REVIEW OF THE LITERATURE

Healthy People 2010 established goals of having at least 90% of children aged 13-15
years fully vaccinated with recommended and catch-up vaccines, and one of the new
objectives of Healthy People 2020 seeks to increase routine vaccination coverage levels
recommended by the ACIP for adolescents aged 13-17, including the influenza vaccine
[25]. Recent additions of human papillomavirus (HPV), tetantus toxoid-reduced
diphtheria toxoid-acellular pertussis, and meningococcal conjugate vaccines to the
adolescent vaccination schedule has renewed interest in understanding how to improve
vaccination rates among adolescents [17]. Although some studies have described
aggregate influenza vaccination rates that include adolescents, very few studies
specifically focus predictors for vaccination on this specific age group.
Influenza-associated pediatric mortality, which includes the adolescent
population, became a nationally notifiable condition in 2004 after a severe 2003-2004
influenza season [11]. Improved understanding of the factors which influence influenza
vaccination in the adolescent age group is also an imperative public health goal as the
recent 2009 A/H1N1 pandemic has highlighted the weaknesses and strengths of modern
global pandemic preparedness and changed the manner in which the world responds to
future pandemics [26]. The pandemic surprised the world in April 2009 by initiating in
Mexico and the U.S., and has also presented challenges because plans to control
pandemics had not been calibrated for a pandemic of milder disease [26].
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Epidemiological tools and prediction models had suggested that an influenza pandemic
would likely start from Asia and spread westward towards Europe, Africa, and the
America [26].

The purpose of this study is to analyze the association between influenza
vaccination status in adolescents aged 13 to 17 and socio-demographic characteristics and
household-reported health status based on data from 2008 National Immunization
Survey- Teen. Socio-demographic characteristics include age, sex, race and ethnicity,
region of the U.S., number of children under the age of 18 in household, health insurance
status, and poverty status. Household-reported health status included whether the teen
had asthma, whether the teen had any other underlying health conditions (including
diabetes, heart conditions, and weakened immune system, etc.), and the number of
missed school days due to illness or injury. Maternal socio-demographic characteristics
include mother’s age, education level, and marital status.
2.1 Virology
Influenza viruses are negative-stranded RNA viruses in the Orthomyxoviridae family
and divided into three majors types: A, B, and C [16]. The three virus types vary in
pathogenicity and host range [8]. Influenza A viruses affect warm-blooded animals,
including birds, swine, horses, humans, and other mammals, and are further characterized
into sixteen hemagglutinin and nine neuraminidase subtypes [8]. Influenza A viral
replication peaks approximately 48 hours after inoculation into the nasopharynx, and the
viruses replicate in both the upper and lower respiratory tract [8]. Novel influenza virus
variants result from frequent antigenic change caused by point mutations (antigenic drift)
6

and recombination events (antigenic shift) that occur during viral replication. As a result,
new influenza A subtypes have the potential to cause a pandemic when they are able to
cause human illness and demonstrated efficient human-to-human transmission and when
little or no previously existing immunity has been identified [1].
Influenza B viruses infect a smaller number of species, namely humans and seals,
and recent circulating influenza B viruses are separated in the Yamagata or Victoria
genetic lineages [8, 13]. Influenza B viruses undergo antigen drift less rapidly than
influenza A viruses and do not cause pandemics [8, 13]. Influenza C viruses are endemic
and sporadically cause mild respiratory disease [8].
2.2. Clinical Course and Epidemiology
Symptoms of influenza infection include onset of high fever, coryza, cough,
headache, prostration, and inflammation of the respiratory tree and trachea [8]. Acute
symptoms and fever often persist for 7 to 10 days, and severe complications from
influenza infection could include hemorrhagic bronchitis, pneumonia, and death [8].
Prevalence of infection is greatest in school-age children while disease severity is greatest
in the elderly, infants, and those with underlying health conditions including chronic
pulmonary or cardiac disease, and diabetes [8]. Diagnosis of influenza infection can be
made by virus isolation, detection of viral proteins, and detection of viral nucleic acid
using nasopharyngeal or throat swabs as well serological assays which detect antibodies
to the influenza virus [1].
Influenza outbreaks have occurred since the Middle Ages and there have been
approximately a dozen influenza A virus pandemics since 1700 [8]. The pandemic of
1918 caused approximately 546,000 excess deaths and killed up to 50 million people
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worldwide [27-28]. Annual influenza epidemics in the United States usually occur in the
fall or winter months but the peak of influenza activity can occur as late as April or May
[13]. Influenza activity during the 2009 H1N1 pandemic peaked in June during the first
wave and mid-October during the second wave [29]. The second wave was also
associated with higher pediatric mortality and higher rates of hospitalization in children
and young adults than in previous five seasons [29].
2.3 Vaccine History
Annual influenza vaccination remains the primary and most effective method of
preventing influenza infection and decreasing viral transmission within a community
[13]. It is also highly cost effective and even cost saving among the elderly, and may be
cost effective for young children and adults [30]. The Armed Forces Commission on
influenza was responsible for the development and evaluation of influenza vaccines in
order to prevent outbreaks of influenza illness in the US military during the Second
World War [31]. Regular evaluations of aqueous whole-virus inactivated vaccines
containing prevalent strains as well as evaluation of various innovative vaccines
continued from 1943 to 1969, but the use of whole viruses in vaccines ended with the
introduction of split or subunit preparation [31].
The vaccine had been efficacious in preventing infections by viruses similar to those
included in the vaccine, but in 1947, antigenic drift caused the vaccine’s efficacy to drop
[32].. After 1977, trivalent vaccines containing 2 representative influenza A subtypes and
a representative B type have been used [33]. Although purity, potency and
standardization of the vaccine has improved, major challenges with the trivalent vaccine
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included limited breadth of immunity, short duration of protection, needle inoculation,
lower protection induced in older individuals, and dependence on egg supply [31].
2.4 Vaccination Types and Recommendations
After the introduction of influenza vaccines for limited use in the military in the
1940s, indications for vaccine use gradually increased [34]. The Advisory Committee on
Immunization Practice (ACIP) has now recommended a universal influenza
immunization policy for seasonal influenza vaccine for all persons aged 6 months and
older for the 2010-2011 influenza season [13]. Children aged 6 months to 8 years are
recommended to receive 2 doses of the 2010-2011 influenza vaccine 4 or more weeks
apart unless 1) they have received either 1 dose of the 2009 H1N1 vaccine last flu season
and 2) at least 1 dose of seasonal vaccine prior to the 2009-2010 influenza season or 2
doses of 2009-10 seasonal flu vaccine last flu season [35]. If a child has fulfilled both
requirements, only 1 dose of the vaccine is needed [35]. All other individuals aged 9 and
older receive only 1 dose.
Prior to the universal recommendation, there have been over 20 indications where
influenza immunization was recommended [34]. Health care professionals, pregnant
women, immunocompromised individuals, and those with chronic heart or pulmonary
disease are special populations which the ACIP targets influenza immunization [13]. In
addition, because children younger than 6 months cannot get a vaccine or antiviral drugs,
but are at high risk for serious flu-related complications, the ACIP recommends the
vaccine for caregivers and household contacts of children less than 6 months old, children
younger than 5 years old, and adults aged ≥50 years old [13, 29]. The ACIP first
recommended annual influenza vaccination of health care workers to reduce nosocomial
9

transmission of influenza to patients at high risk for infection in 1986 [36]. Healthy
children less than 2 years of age had not been included in recommendation for routine
influenza vaccination until the 2002-2003 season [37]. Finally, in 2008 ACIP expanded
their recommendation to include not only persons aged 50 and over, 18-49 years at higher
risk for influenza complications, and 6 months to 4 years of age, but also all children
aged 5-18 for the 2008-2009 influenza season [38].
Currently, the two types of vaccine available are the trivalent inactivated vaccine
(TIV) administered by intramuscular infection and the live attenuated (LAIV)
administered by intranasal spray. Whereas TIV contains inactivated viruses and cannot
cause influenza, LAIV contains live attenuated influenza viruses that have the potential to
cause mild signs or symptoms related to vaccine virus infection [13]. Currently, both
contain two types of influenza A (H1N1 and H3N2) and one B-strain, and have been
proven to be safe and effective [39]. TIV is licensed for use among person aged 6 months
and older for those with chronic medical conditions and those who are healthy, but LAIV
is only licensed for use among non-pregnant persons aged 2-49 years [13]. Safety or
effectiveness of LAIV has not been established in persons with underlying medical
conditions that confer a higher risk for influenza complications [13].
TIV is contraindicated to persons who have anaphylactic hypersensitivity to eggs or
to other components of the influenza vaccine, and prophylactic use of antiviral agents is
an option for preventing influenza among such persons [13]. Persons with moderate or
severe acute illness with or without fever is a precaution for TIV and Guillain-Barré
Syndrome within 6 weeks following a previous dose of influenza vaccine is considered to
be a precaution for use of influenza vaccine [13].
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2.5 Vaccination Supply and Coverage
The annual supply of influenza vaccine and the timing of its distribution cannot be
guaranteed in any year, and distribution delays or vaccine shortages remain possible [13].
The U.S. has experienced disruptions in the manufacture or distribution of inactivated
influenza vaccine in 4 seasons during the last decade [40-41]. If supplies of season
influenza vaccine are not adequate, vaccination is carried out in accordance with local
circumstances of supply and demand based on the judgment of state and local health
officials and health-care providers [13]. Multiple manufacturing and regulatory issues,
and inherent critical time constraints in manufacturing the vaccine given the annual
updating of influenza vaccine strains may affect production [13]. During shortages of
TIV, LAIV is recommended when feasible for all healthy non-pregnant persons aged 249 who desire or are recommended for vaccination in order to increase the availability of
inactivated vaccine for persons at high risk [13].
The Centers for Disease Control and Prevention (CDC) routinely monitors influenza
vaccination coverage levels using Behavioral Risk Factor Surveillance System (BRFSS),
the National Immunization Survey (NIS), the National Health Interview Survey (NHIS),
and eight sentinel immunization information system (IIS) sites located in the United
States [38]. Specifically, the NIS was established to fulfill the 1992 Childhood
Immunization Initiative (CII) mandate of monitoring vaccination coverage and progress
towards achieving the Healthy People 2010 objective of having at least 90 percent of
children aged 13-15 years fully vaccination with recommended and catch-up vaccines
[42]
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Influenza vaccine coverage in all recommended groups remains suboptimal and
below Healthy People 2010 objectives [13]. Recent NHIS estimates of vaccine coverage
levels among adults with high-risk conditions aged 18-49 years were 30.4% in the 200708 season and 33% in the 2008-09 season [13]. Among adults with asthmas aged 18-49
years and 50-64 years, approximately 24% and 55%, respectively received the
vaccination [13]. Vaccination levels are reportedly not only low among children at
increased risk for influenza complications but also decline with increasing age [13].
Coverage among children with asthma aged 2-17 years was approximately 29% for the
2004-05 influenza season [43]. Data from the eight IIS sentinel sites also revealed that
coverage was 29% among children aged 6-23 months, 22% among children 2-4 years,
and 9% among children aged 13-18 years [44].
2.6 Vaccination Predictors
Although many studies have investigated predictors associated with influenza vaccine
coverage among high-risk or ACIP recommended groups, few studies have examined
predictors among healthy adults [45]. Among the ACIP recommended or high-risk
groups, perceived doctor’s recommendations, belief that getting the influenza vaccine is a
“smart idea”, concern about vaccine side-effects, and perception that the vaccine was not
needed have been found to be predictors of influenza vaccination [46-47]. The available
studies among healthy adults reveal that predictors of vaccine acceptance are similar to
those of high-risk patient population and health care workers [48].
Few studies have also examined the influence of socioeconomic and demographic
factors and influenza vaccination. Results of a few studies have suggested that parental
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education status, gender, household income, and size of household may significantly
contribute to chances of getting immunized [2, 45].
Reducing racial and ethnic disparities in influenza coverage also presents a national
public health challenge [13]. Although adult influenza vaccination levels have increased
in the past decade, recent studies continue to document racial and ethnic differences in
vaccination coverage [49]. Vaccination coverage levels in 2008 among person aged 65
and over were 70% for non-Hispanic whites, 52% for non-Hispanic blacks, and 52% for
Hispanics [13]. In a study among nursing home patients, fewer blacks and Hispanics
were offered vaccine or received it compared with whites, and blacks refused vaccination
more frequently [50].
2.7 Influenza, Vaccinations, and Adolescents
Influenza vaccine may be comparatively more effective among children and
adolescents and
studies have demonstrated a definite advantage over influenza vaccination in this age
group [22]. Unfortunately, studies have found that missed opportunities, lack of
population-based immunization registries that include adolescents, low public and peer
awareness about immunization covered in this age group, misperceptions about vaccine
safety, and lack of knowledge about the importance of vaccinations all contribute to low
immunization rates [51]. Although healthy adolescents are not a high-risk group for
severe influenza infection, they still may act as vectors for transmitting disease to
contacts and family members considered high risk [22]. In addition, with the emergence
of new influenza strains, patterns of disease severity diverging from previous experiences
have been observed [22]. For example, cases of adolescents and young adults suffering
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severe H1N1 influenza have been reported much more frequently [22]. With the increase
in bacteria co-infections seen in the older pediatric population, reducing the risk of
influenza infection could also presumably reduce the invasive bacterial infections that are
facilitated by disruptions in host defenses during influenza virus infection [11].
Summary
Influenza vaccines are among the oldest of successful vaccines that are still in use
and deficiencies are being addressed by a number of innovative approaches in vaccine
development [31]. Despite the burden of influenza infection and universal vaccination
recommendation, studies have suggested that coverage in all groups remain low [13].
Additional research should be done to investigate opportunities how to improve coverage
as well as education to both health care providers and general public.
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Chapter III
METHODOLOGY
3.1 Data Source
The data used in this study were obtained from the 2008 National Immunization
Survey (NIS) Teen, a publicly available database that contains de-identified information.
The NIS is sponsored by the National Center for Immunizations and Respiratory Diseases
(NCIRD) and is conducted jointly with the National Center for Health Statistics (NCHS)
of the Centers for Disease Control and Prevention. Established as part of the Childhood
Immunization Initiative by President Clinton, the NIS is a list-assisted, random-digitdialing telephone survey followed by a mailed survey to participants’ immunization
providers. Telephones numbers are drawn independently, for each quarter, within
selected geographical areas. The survey began data collection in April 1994 to monitor
childhood immunization coverage and is repeated annually.
NIS is targeted to children ages 19-35 months living in the United States at the
time of the interview and the data collected are used to produce estimates of vaccination
coverage rates for all childhood vaccinations recommended by the ACIP. However, to
assist in measuring progress towards the Healthy People 2010 objectives for teens, the
NIS-Teen was developed and conducted for the first time in 2006 as an expansion of NIS.
If a household with a 19-35 month old child is identified and the NIS interview is
completed, the household is then screened for the presence of any13-17 year old children.
Households that do not have a 19-35 month old child are immediately screened for the
presence of 13-17 year-old children. If a household contains one or more children aged
15

13-17, a teen is randomly chosen and the adult who is most knowledgeable about the
teen’s vaccinations is interviewed. With the consent of the teen’s parents or guardian,
NIS-Teen also follow-up via mail with the teen’s health care provider(s) to request
information on the teen’s vaccination status from medical records. Survey participation
is voluntary and confidential.
NIS provides data online in ASCII format and interested users are allowed to
download the files into a variety of statistical software. Syntax files for SAS and R are
provided on the NIS website. The 2008 NIS-Teen data files were downloaded from the
NIS website and converted from a SAS7bdat file for Statistical Package for Social
Sciences (SPSS) version 18.0. SPSS 18 was used for all analysis in this study.
3.2 Study Population
The target population for NIS-Teen was children aged 13-17 living in noninstitutionalized households in the United States at the time of the interview. Household
interviews began January 3, 2008 and ended on February 4, 2009. All fifty states,
including the District of Columbia, were surveyed. Findings from the surveys were
released only in summary form. In this study, only data from the 2008 survey were
available and utilized.
3.3. Study Measures and Variables
The primary dependent variable for this study was the teen’s receipt of influenza
vaccination in the last 12 months based on the respondent’s recall. The January 2008 to
February 2009 timeframe of the household interviews allows for the possibility that
influenza vaccination status could be in response for the 2006-2007, 2007-2008, and
2008-2009 influenza seasons.
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The demographic independent variables for each household included: sex, age,
race and ethnicity, region of U.S., and number of children under the age of 18 living in
the household. The socioeconomic independent variables used in this study were poverty
status and health insurance status. Poverty status was based on the 2007 Census poverty
threshold of $14, 291 in a two person household with 1 child under the age of 18 [52] .
Types of health insurance surveyed included: employer health insurance, Medicaid, SCHIP, Indian Health Services, Military/Tricare/CHAMPUS/CHAMP-VA, or other form
of health insurance not named.
The household-reported health status included whether or not the teen had been
told by a health professional that he or she has asthma or an underlying health condition.
Underlying conditions was defined by the NIS as having a lung condition other than
asthma, a heart condition, a kidney condition, sickle cell anemia or other anemia, a
weakened immune system caused by a chronic illness or by medicines taken for a chronic
illness. These underlying health conditions are typically risk factors which may put
individuals at higher risk for complications from influenza infection. The number of
school days missed due to illness or injury was also collected. Maternal sociodemographic characteristics included mother’s age, education level, and the marital
status.
Variables that were taken directly as coded from the original data set were: age,
race and ethnicity, region of U.S., asthma status, and underlying health condition. Race
and ethnicity was coded as non-Hispanic white, non-Hispanic black, non-Hispanic other
race and multirace. Hispanic or Latino included those who identified the teens as
Mexican, Mexican-American, Central American, South American or Puerto Rican,
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Cuban, or other Spanish- Caribbean. Non-Hispanic other race or multirace included
Native American, Alaskan native, Asian, Native Hawaiian, Pacific Islanders, and those
who identified the teens as “Other.” Other variables that were used as coded in the
original data set included the number of children under 18 in the household, poverty
status, and the maternal socio-demographic characteristics. Poverty status was recategorized by NIS into the follow three groups: above poverty and > $75k, above
poverty <= $75k, and below poverty. Mother’s age was grouped into 34 years of age and
younger, 35-44 years, and 45 years of age and older. Mother’s education level was
grouped into the following: less than 12 years, 12 years, more than 12 years but noncollege graduate, and college graduate. Mother’s marital status was grouped into
widowed/divorced/separated, never married, and married.
The following variables were re-categorized in the current analysis: health
insurance and days of school missed. Health insurance status was re-categorized to a
dichotomous variable that was zero if the teen reported no insurance and one if the teen
was covered by one or more form of the following health insurance plans listed above.
The number of missed school days by teen due to illness or injury was re-categorized into
the following: 0, 1 to 9 days, 10-19 days, 20-29 days, and 30 or more.
3.4 Statistical Analysis
Descriptive statistics were created to describe the population sample. An odds
ratio calculation was performed to analyze any association between receipt of influenza
vaccination and socio-demographic characteristics and household-reported health status.
Using a binary logistic regression analysis, odds ratios were calculated along with 95%
confidence intervals and p-value. A p-value of < 0.05 was considered a statistically
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significant association between the socio-demographic factors, household-reported health
status, with receipt of the vaccine.
To further examine potential associations between the dependent and independent
variables, multivariate logistic regression analysis was performed for influenza vaccine
receipt where all socio-demographic characteristics and household-reported health status
variables were considered at once. Odds ratios were calculated, along with 95%
confidence intervals and variables were considered significantly associated with receipt
of the influenza vaccine at the aforementioned accepted p-value of < 0.05.
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Chapter IV
RESULTS

4.1 Frequencies and Descriptive Statistics
Frequencies and descriptive statistics about the study sample are detailed in
Tables 1 through 6. The sample size for this study included 29063 adolescents where
19.8% of the respondents reported receiving the influenza vaccine (Table 1). A total of
1,618 respondents who reported not knowing the influenza vaccination status, refused to
respond, or had a missing response and were excluded from this analysis.
In this study population, 51.9% were male and 48% were female. Limited data
were available for influenza vaccine type, month of vaccination, and place of vaccination.
These results are presented in Tables 1 and 2.
Of the five age categories, the 16 year old age group was the most represented
category with 21.4% of the respondents. Non-Hispanic whites were the most represented
race/ethnicity among the study population (68.6%) and non-Hispanic other race and
multirace were the least represented race/ethnicity (7.1%). More than one third (36.4%)
of the study population resided in the South, and approximately one half of the teens
(50.9%) lived in households with 2 or 3 children under the age of 18.
Of those surveyed where information on income and health insurance status was
obtained, almost half (46.6%) of the study population reported annual family income
above the 2007 U.S. Census Bureau poverty threshold and less than or equal to $75,000,
and 93.3% reported having one or more form of health insurance. Nonresponse as a result
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of refusal to answer, lack of knowledge, or dropped interview resulted in 6 percent of the
poverty status and 20 percent of the health insurance unavailable for analysis. The results
are presented in Table 4.
Of those surveyed where the teen’s household-reported health status was
available, 18.1% reported having been told by a health professional that the teen had
asthma, and 5.8% reported having been told he or she has an underlying health condition.
The results are presented in Table 5.

Table 1. Influenza Vaccine Receipt Data
Vaccine Receipt

N (%)

Yes

5752 (19.8)

No

23311 (80.2)
29063
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Table 2. Influenza Vaccine Descriptive Data by Type, Place, and Month of Vaccination

Vaccine Type

N (%)

Shot

5184 (94.1)

Spray/Mist

324 (5.9)
5508

Place of Vaccination

N (%)

Doctor’s Office

3330 (58.1)

Health Department

331 (5.8)

Clinic

1087 (19.0)

Hospital

235 (4.1)

Other Medical Facility

102 (1.8)

Pharmacy

169 (2.9)

Work

65 (1.1)

Other Non-Medical Place

417 (7.3)
5736
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Table 2. Influenza Vaccine Descriptive Data by Type, Place, and Month of Vaccination Cont’d
Month

N (%)

January

194 (3.7)

February

118 (2.2)

March

52 (1)

April

30 (0.5)

May

30 (0.5)

June

20 (0.4)

July

23(0.4)

August

123 (2.3)

September

412 (7.9)

October

2088 (40.0)

November

1709 (32.8)

December

411 (7.9)
5210
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Table 3. Demographic Characteristics and Vaccination Status of NIS Teen 2008 Influenza
Vaccination Study Population
Demographic
Characteristic

N (%)

No. Vaccinated (%)

Male
Female
Total

15111 (51.9)
13952 (48.0)
29063

2867 (19.0)
2885 (20.7)

Age
13
14
15
16
17
Total

5395 (18.6)
5850 (20.1)
5953 (20.4)
6212 (21.4)
5633 (19.4)
29063

1147 (21.2)
1250 (21.3)
1173 (19.7)
1170 (18.8)
1012 (18.0)

19946 (68.6)
3516 (12.1)
3535 (12.2)
2066 (7.1)

3579 (17.9)
777 (22.1)
831 (23.5)
565 (27.3)

Sex

Race and Ethnicity
Non-Hispanic White
Hispanic
Non-Hispanic Black
Non-Hispanic Other
& Multirace
Total

29063

Region of U.S.
Northeast
Midwest
South
West
Total

5469 (18.8)
6823 (23.5)
10571 (36.4)
6200 (21.3)
29063

1099 (20.1)
1240 (18.2)
2214 (20.9)
1199 (19.3)

No. of Children < 18 in
Household
1
2 or 3
4 or more
Total

11594 (39.9)
14796 (50.9)
2673 (9.2)
29063

2204 (19.0)
2978 (20.0)
570 (21.3)
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Table 4. Socioeconomic Characteristics and Vaccination Status of NIS Teen 2008 Influenza
Vaccination Study Population
Socio-demographic
Characteristics
Poverty Status
Above Poverty >75k
Above Poverty <=75k
Below Poverty
Missing/Don’t
know/Refused
Total
Health Insurance
Status
Insured
Not Insured
Missing/Don’t
Know/Refused
Total

N (%)

No. Vaccinated (%)

11044 (38.0)
12679 (43.6)
3471 (11.9)
1869 (6.4)

2292 (20.8)
2296 (18.1)
807 (23.0)

29063

5395

21773 (74.9)
1553 (5.3)
5954 (20.5)

4361 (20.0)
217 (14.0)

29063

4587
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Table 5. Household-reported Health Status and Vaccination Status of NIS Teen 2008 Influenza
Vaccination Study Population
Household-reported Health
Status

N (%)

No. Vaccinated

Has been told he/she has
asthma
Yes
No
Missing/Don’t Know/Refused
Total

5286 (18.2)
23736 (81.7)
41 (0.14)
29063

1572(29.7)
4167 (17.6)

Has ever been told he/she had
underlying health
condition?*
Yes
No
Missing/Don’t Know/Refused
Total

1688 (5.8)
27347 (94.1)
28 (0.1)
29063

528 (31.2)
5216 (19.1)

8212 (28.3)
18033 (62.0)
1862 (6.4)
337 (1.2)
342 (1.2)
277 (0.95)

1544 (18.8)
3491 (19.4)
446 (24.0)
92 (27.3)
95 (27.8)

No. of Missed School Days
because of Illness or Injury
0
1 to 9
10-19
20-29
30 or more
Missing/Unknown/Refused/Did
not go to school
Total

29063
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Table 6. Maternal Socio-demographic Characteristics and Vaccination Status of NIS Teen 2008
Influenza Vaccination Study Population
Maternal Socio-demographic
Characteristics

N

No. Vaccinated (%)

Mother’s Age
<=34 yrs
35-44 yrs
>=45 yrs
Total

2342 (8.1)
13157 (45.3)
13564 (46.7)
29063

546 (23.3)
2538 (19.3)
2688 (19.8)

Mother’s Education Level
< 12 yrs
12 years
>12 years, Non-college graduate
College graduate
Total

2879 (10.0)
6336 (21.8)
8907 (30.6)
10941 (37.6)
29063

614 (21.3)
1174 (18.5)
1684 (18.9)
2280 (20.8)

Mother’s Marital Status
Widowed/Divorced/Separated
Never Married
Married
Total

5099 (17.5)
2027 (7.0)
21937 (75.5)
29063

1013 (19.9)
497 (24.5)
4242 (19.3)
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With regards to maternal socio-demographic characteristics, teens with mothers in
the 45 and older age group were the most represented (46%) whereas only 8.1% of teens
with mothers were in the 34 and younger age group. More than one third (36.7%) of the
respondents reported that the teen’s mother was a college graduate, and approximately
three quarters (75.5%) reported that the teen’s mother was married.
Frequency and prevalence of influenza vaccination are also detailed in Tables 3
through 6. Females, 14 year olds, non-Hispanic other race and multirace, the southern
region of the U.S., and households with four or more children under 18 years of age had
the highest prevalence of vaccination in the study population. Descriptive results revealed
that 20% of the female adolescents were vaccinated compared with 19% of males.
Approximately 21% of 14 year old teens in this study reported receiving the vaccination.
Approximately 27 % of teens in the non-Hispanic other race and multirace category
reported receiving the influenza vaccine, where as only 17.9% of the non-Hispanic white
teens reported receiving the influenza vaccine. Teens who resided in the Southern region
of the U.S. reported the highest prevalence of vaccination at 20.9% whereas teens who
resided in the Midwest reported a prevalence of only 18%. Finally, 21% of teens in the
survey who resided in households with 4 or more children under the age of 18 were
vaccinated.
With regards to socioeconomic factors, teens with one or more form of health
insurance, and teens who reported living below poverty had highest prevalence of
influenza vaccination. With regards to household-reported health status, teens who
reported having asthma and underlying health conditions, and those who reported missing
30 or more days of school due to illness or injury all reported having the highest
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prevalence of vaccination. Teens whose mothers were in the 45 years of age and older
age group, mothers who had less than 12 years of education, and mothers who never
married were found to have the highest prevalence of influenza vaccination in the study
population.
4.2. Demographic characteristics
Bivariate analysis using logistic regression assessed the association of
demographic characteristics with the receipt of influenza vaccine. The results are shown
in Table 7. With regards to sex, females were 1.11 times more likely to receive the
vaccine compared with males. Age also played a significant role in the odds of receiving
the vaccine where a one year increase in age resulted in a slight decrease (OR=0.94) in
the odds of vaccination (p< 0.001). Those who were identified themselves as nonHispanic other race and multi-race teens were the most likely to have received the
influenza vaccine compared to non-Hispanic whites (OR=1.72). When region of the U.S.
was analyzed, the only subcategory found to be statistically significant was the Midwest
(OR=0.88, p=0.007). Teens who lived in households which had four or more children
under 18 were 1.16 times more likely to receive the vaccine as compared to those who
had only one child under the age of 18 (p=0.006).
Additional analysis of the demographic factors influencing influenza vaccine
receipt was performed by including all of the independent variables in a multivariate
logistic regression model. Results are presented in Table 11. Both sex and race/ethnicity
remained statistically significant. Females 1.15 times more likely to receive the vaccine
than males and non-Hispanic other race & multirace teens were 1.71 times more likely to
receive the vaccine compared with the non-Hispanic white referent group. Age also
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remained statistically significant where a one year increase in age resulted in a slight
decrease in odds of vaccination (OR=0.95,p< 0.001). Region of U.S., and number of
children under 18 in the household were no longer statistically significant in the
multivariate model.
Table 7. Bivariate Analysis Using Logistic Regression Assessing the Association of Demographic
Characteristics in NIS Teen 2008 Influenza Vaccination Study Population
Variable

OR

CI

p-value

REF
1.11

REF
1.05-1.18

REF
<0.001

Age

0.94

0.92-0.96

<0.001

Race and Ethnicity
Non-Hispanic White
Hispanic
Non-Hispanic Black
Non-Hispanic Other
& Multirace

REF
1.30
1.41
1.72

REF
1.19-1.42
1.29-1.53
1.55-1/91

REF
<0.001
<0.001
<0.001

Region of U.S.
Northeast
Midwest
South
West

REF
0.88
1.05
0.95

REF
0.81-0.97
0.97-1.14
0.87-1.05

REF
0.007
0.21
0.31

No. of Children < 18 in
Household
1
2 or 3
4 or more

REF
1.07
1.16

REF
1.01-1.13
1.04-1.28

REF
0.023
0.006

Sex
Male
Female
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4.3 Socioeconomic Characteristics
Bivariate analysis using logistic regression assessed the association of
socioeconomic characteristics with the receipt of influenza vaccine. The results are
shown in Table 8. The analysis of both poverty status and health insurance status
indicated that both were correlated with receipt of the influenza vaccine. Teens who
lived below poverty were 1.16 times more likely while teens who lived above poverty
but less than or equal to $75,000 were less likely (OR=0.86, p<0.001) to receive the
influenza vaccine when compared with the referent group (teens who lived above
poverty and more than $75,000). Teens who had at least one form of health insurance
were 1.54 times more likely to have received the vaccine compared to those who
reported no health insurance.
Additional analysis of the socioeconomic factors influencing influenza vaccine was
performed by including all of the independent variables in a multivariate logistic
regression model. Poverty status remained statistically significant, but only in the
category of those who reported annual income above the poverty threshold but less than
or equal to $75,000. Health insurance also remained a statistically significant predictor
of influenza vaccination. (OR=1.54, p<0.001).
Table 8. Bivariate Analysis Using Logistic Regression Assessing the Association of Socioeconomic
Characteristics in NIS Teen 2008 Influenza Vaccination Study Population
Variable
Poverty Status
Above Poverty >75k
Above Poverty <=75k
Below Poverty

OR

CI

p-value

REF
0.84
1.16

REF
0.79-0.90
1.06-1.27

REF
<0.001
0.002

Health Insurance

1.54

1.33-1.79

<0.001

4.4 Household-reported Health Status
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Analysis of the teens’ household-reported health status indicated that teens who
had asthma and other underlying health conditions, and missed more days of school were
all more likely to receive the vaccine. All three independent variables measuring teen
health status were significantly associated with receipt of influenza vaccine, and the
results are presented in Table 9. All three also remained statistically significant when
included in the multivariate model but the strength of the associations were lower after
adjustment for other factors.
4.5 Maternal Socio-demographic Characteristics
Independent analysis of maternal socio-demographic characteristics indicated that all
three independent variables were statistically associated with receipt of influenza vaccine.
Teens whose mothers were in the 35-44 age group were the least likely (OR=0.79,
p<0.001) to receive the influenza vaccine compared with the referent group (mothers
aged 34 or younger). Teen whose mothers were in the 45 years and older age group were
also less likely to receive the vaccine compared with the referent group (OR=0.81,
p<<0.001). Teens whose mothers who completed high school only were the least likely
(OR=0.84, p=0.002) to receive the vaccine compared with the referent group (less than
12 years of school). Teens whose mothers who were never married were 1.31 times more
likely to receive the vaccine compared with the widowed/divorced/separated referent
group (p<0.001).
After adjusting for other variables, the only significant maternal socio-demographic
characteristics variable was maternal age. Similar to the results from the bivariate
analysis, teens whose mothers were in 35-44 age group were the least likely to receive the
influenza vaccine compared with the referent group (mothers aged 34 or younger).
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Table 9. Bivariate Analysis Using Logistic Regression Assessing the Association of Householdreported Health Status in NIS Teen 2008 Influenza Vaccination Study Population
Variable

OR

CI

p-value

Has been told teen has
asthma

1.99

1.86-2.13

<0.001

Has ever been told teen had
underlying health
condition?*

1.93

1.74-2.15

<0.001

Still has the underlying
health condition

1.76

1.42-2.19

<0.001

REF
1.04
1.36
1.62
1.66

REF
0.98-1.11
1.21-1.53
1.27-2.07
1.30- 2.12

REF
0.288
<0.001
<0.001
<0.001

No. of Missed School Days by
teen because of illness or
injury
0
1 to 9
10-19
20-29
30 or more
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Table 10. Bivariate Analysis Using Logistic Regression Assessing the Association of Maternal Sociodemographic Characteristics in NIS Teen 2008 Influenza Vaccination Study Population
Variable
Mother’s Age
<=34 yrs
35-44 yrs
>=45 yrs
Mother’s Education Level
< 12 yrs
12 years
>12 years, Non-college
graduate
College graduate

OR

CI

p-value

REF
0.79
0.81

REF
0.71-0.87
0.73-0.89

REF
<0.001
<0.001

REF
0.84
086

REF
0.75-0.94
0.78-0.95

REF
0.002
0.004

0.97

0.88-1.07

0.57

REF

REF

REF

1.31
0.97

1.16-1.48
0.90-1.04

<0.001
0.39

Mother’s Marital Status
Widowed/Divorced/Separated
Never Married
Married
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Table 11. Multivariate Analysis Using Logistic Regression Assessing the Association of Sociodemographic Characteristics in NIS Teen 2008 Influenza Vaccination Study Population
Variable

OR

CI

p-value

REF
1.15

REF
1.07-1.23

REF
<0.001

Age

0.95

0.92-0.97

<0.001

Race and Ethnicity
Nonhispanic White
Hispanic
Nonhispanic Black
Nonhispanic Other
& Multirace

REF
1.33
1.29
1.71

REF
1.19-1.49
1.14-1.44
1.51-1.93

REF
<0.001
<0.001
<0.001

Region of U.S.
Northeast
Midwest
South
West

REF
0.93
1.04
0.93

REF
0.84-1.04
0.94-1.14
0.83-1.04

REF
0.19
0.45
0.19

No. of Children < 18 in
Household
1
2 or 3
4 or more

REF
1.07
1.12

REF
0.99-1.16
0.98-1.30

REF
0.08
0.10

Poverty Status
Above Poverty >75k
Above Poverty <=75k
Below Poverty

REF
0.80
0.96

REF
0.74-0.87
0.84-1.09

REF
<0.001
0.55

Health Insurance

1.50

1.27-1.75

<0.001

Has been told teen has
asthma

1.90

1.75-2.06

<0.001

Has ever been told teen
had underlying health
condition?*

1.70

1.50-1.93

<0.001

Sex
Male
Female
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Table 11. Multivariate Analysis Using Logistic Regression Assessing the Association of Sociodemographic Characteristics in NIS Teen 2008 Influenza Vaccination Study Population Cont’d

Variable
No. of Missed School Days by
teen because of illness or
injury
0
1 to 9
10-19
20-29
30 or more

OR

CI

p-value

REF
1.03
1.31
1.54
1.47

REF
0.95-1.12
1.14-1.51
1.17-2.04
1.11-1.95

REF
0.44
<0.001
0.002
0.007

Mother’s Age
<=34 yrs
35-44 yrs
>=45 yrs

REF
0.81
0.86

REF
0.71-0.91
0.75-0.98

REF
0.01
0.03

REF
0.92
0.96

REF
0.81-1.05
0.84-1.10

REF
0.23
0.54

1.06

0.92-1.21

0.43

REF

REF

REF

1.16
0.99

1.00-1.35
0.90-1.09

0.05
0.83

Mother’s Education Level
< 12 yrs
12 years
>12 years, Non-college
graduate
College graduate
Mother’s Marital Status
Widowed/Divorced/Separated
Never Married
Married

*Underlying health condition was defined as having a lung condition other than asthma, a heart
condition, a kidney condition, sickle cell anemia or other anemia, a weakened immune system caused
by a chronic illness or by medicines taken for a chronic illness.

4.6 Significant Association
Table 12 shows a summary of the statistically significant socio-demographic
characteristics and household-reported health status based on the bivariate and
multivariate analyses performed for this study.
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Sex, age, race and ethnicity, residing in the Midwest region, poverty status, health
insurance, having asthma, having an underlying health condition, higher number of
missed school days, and mother’s age, mother’s education level, and mother’s marital
status were found to be statistically significant with the receipt of vaccination using the
bivariate logistic regression model. Sex, age, race and ethnicity, living above poverty but
less than $75,000, health insurance, having asthma, having an underlying health
condition, higher number of missed school days, and mother’s age were found to be
statistically significantly with the receipt of vaccination using the multivariate logistic
regression model.
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Table 12. Summary of Bivariate and Multivariate Analyses Statistically Significant Sociodemographic Characteristics and Household-reported Health Status for NIS Teen 2008 Influenza
Vaccination Study Population
Variable
Female
Age
Hispanic
Nonhispanic Black
Nonhispanic Other Race and
Multirace
Midwest
South
West
No. of children < 18: 2 or 3
No. of children <18: 4+
Above Poverty<=$75k
Below Poverty
Health Insurance
Asthma
Underlying Health Condition
No. of Missed School Days: 1-9
No. of Missed School Days: 10-19
No. of Missed School Days 20-29
No. of Missed School Days: 30+
Mother’s Age: 35-44 yrs
Mother’s Age: >=45 yrs
Mother’s Education Level: 12 yrs
Mother’s Education Level: >12 yrs,
Non-college graduate
Mother’s Education Level: College
graduate
Mother’s Marital Status: Never
Married
Mother’s Marital Status: Married

Bivariate analysis p-value
<0.001
<0.001
<0.001
<0.001
<0.001

Multivariate analysis p-value
<0.001
<0.001
<0.001
<0.001
<0.001

0.007
0.21
0.31
0.023
0.006
<0.001
<0.001
<0.001
<0.001
<0.001
0.29
<0.001
<0.001
<0.001
<0.001
<0.001
0.002
0.004

0.19
0.45
0.19
0.08
0.10
<0.001
0.55
<0.001
<0.001
<0.001
0.44
<0.001
0.002
0.007
0.01
0.03
0.23
0.54

0.57

0.43

<0.001

0.05

0.39

0.83
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Chapter V
Discussion and Conclusion
5.1 Discussion
.

High influenza vaccination coverage of school-aged children not only provides

both direct and indirect protection to students, school staff, and the broader community,
but it also reduces student and teacher absenteeism [14]. Studies have demonstrated that
encouragement from health care professionals can lead to beneficial health practices and
higher vaccination rates[45]. However, primary care visits would have to increase by
more than two thirds to achieve high vaccine coverage of 5 to 18 year olds [14].
Physician case loads have been near capacity with previous influenza vaccination
recommendations and relying solely on the primary care provider could exacerbate
existing health care disparities [14]. In addition, reminder and recall systems and
reducing missed opportunities have only had limited success in increasing vaccination
rates and do not account for the population of teens who are uninsured or do not see the
same health care professional each time [14]. Reminder systems also do not address the
disparities among different socio-demographic characteristics or the time and cost parents
must spend to vaccinate their children.
The purpose of this work was to examine the association between specific sociodemographic characteristics and household-reported health status with receipt of
influenza vaccinations in teens. Studies on the characteristics that describe the vaccinated
portion of the adolescent population will allow public health and health care professionals
implement appropriate interventions aimed at improving adolescent vaccination rates.
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Demographic Characteristics
Sex
Results from the multivariate analysis in this study revealed that female teens
were more likely than male teens to receive the influenza vaccination. Some studies of
health services use among school-aged patients revealed no differences according to sex
[17]. However, another study determined older adolescent female subjects had more
overall visits, largely because of visits to obstetricians/gynecologists [17]. Obstetriciangynecologists are the first and most frequent point of contact for women who seek
medical consultation for reproductive health and are primary caregivers for many nonpregnant women who have little or no contact with the healthcare system [53]. It is also
possible this study population had female teens who were pregnant during influenza
season and thus were recommended to receive the vaccine. The statistical significance
found in the analysis could also be due to a large sample size, and exact reasons for a
higher likelihood of female teen influenza vaccination in this study population are
unclear. Further research is needed to explore this association.
Age
Results from this multivariate analysis revealed that age was a statistically
significant predictor with influenza vaccination in this study population. The lower
vaccination coverage found in older adolescents may have resulted from greater parental
or health care provider influence on younger adolescents regarding immunization [17].
For example, providers have reported that they are more likely to assess immunization
status and to administer immunizations in younger adolescents [51]. It is also important
to note that adolescents in the 13-17 age group, except those who had underlying health
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conditions, had not been included in any of the ACIP influenza recommended groups
until the 2008-2009 influenza season [38]. Given these findings as well as the change to
a universal recommendation by ACIP following the influenza A H1N1 pandemic of
2009, further research is needed to explore the association of the age and influenza
vaccination.
Race
Results from the multivariate analysis revealed race and ethnicity was a
significant predictor of influenza vaccination. However, findings from this study
differed from what has been reported previously in the literature and in general trends
noted in many social determinant studies, where Whites typically have fewer health
problems and tend to have better health and fewer disparities to overcome with regards
to health [54]. Although they constituted less than 10 percent of the study population,
teens in the non-Hispanic other race and multirace group were the most likely to receive
the vaccine compared with non-Hispanic white teens. It is unclear whether the lower
immunization rates in the non-Hispanic white teens might be a reflection of the poor
overall coverage or whether having better health might have led to the false perceptions
that influenza is a mild disease and therefore the vaccine is not needed. It is also
possible the higher likelihood of influenza vaccination seen in teens in the non-Hispanic
other race and multirace category was a result of targeted immunization campaigns as a
result of socioeconomic status or underlying health conditions. Further research is
needed to assess the association between influenza vaccination and race and ethnicity, as
well as any immunization interventions received among the different race and ethnic
groups.
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Region of the U.S.
Region of the U.S. did not reveal trends that could show an overall association
between region and likelihood of influenza vaccination. Although review of the
literature did not indicate whether any region perceived higher risk of infection, or were
more or less likely to receive the influenza vaccination, an important point to consider is
that an universal vaccination strategy may not work across all cities with the same level
of effectiveness [55]. There is no clear explanation for the results found in this study and
regions might have been a proxy for other factors which predict adolescent vaccination.
It is also important to note the local and state public health departments differ in their
capacity to administer vaccinations. Many public health clinics do not have adequate
capacity to bill and recover the costs of immunizations, 24 states are unable to provide
vaccines for underinsured children in the private sectors, and only 56% of public health
department immunization clinics use tracking and recall system [14, 53, 56]. More
appropriate variables for this examination may have been population size, urban versus
rural area, or distance and travel time required to receive vaccinations.
Number of children under 18 in household
Although trends from the descriptive data and odds ratio from the bivariate analysis
indicated that teens were more likely to receive the influenza vaccination as the number
of children under 18 in the household increased, results from the multivariate model
revealed that after adjusting for other variables, the number of children was not a
statistically significant predictor for receipt of influenza vaccination. Previous research
has revealed mixed findings with household size and immunization coverage. One study
of Latino and African-American preschool aged children suggested that an increase in the
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number of preschool aged children in the household resulted in lower likelihood of
receiving childhood immunizations with [57]. A European study on socioeconomic
determinants and influenza vaccination found that person living in two persons
households were more likely to be vaccinated but living in a household with three or
more persons had a negative effect on the vaccination rate [2]. The number of children
could be a proxy for other factors and further studies should analyze the impact of both
age group and number of children and persons in the household. It is possible that a more
appropriate variable could have been one which stratified the age groups of children in
the household as literature has shown that office visits for preventive and episodic care
are less frequent for school-aged children than for infants and preschool children [14].
Socioeconomic Characteristics
Poverty Status
Results from this analysis revealed that after adjusting for other variables, poverty
status was only a statistically significant for receipt of influenza vaccination for teens
who reported living above poverty but less than or equal to $75,000. Teens who lived
above poverty but reported annual household income of less than $75,000 were less
likely than teens in the referent group (above poverty but reported an annual household
income of more than $75,000) to receive in the influenza vaccine. Although teens who
lived below poverty were also found to be less likely to receive the influenza vaccine
compared with the referent group, this association was not statistically significant.
Although cost is not a barrier for vaccinations for the majority of children in the U.S.
[56], the findings from this study are consistent with previous findings that lower income
levels contribute to the inability of obtaining health insurance, and the cost to families is a
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barrier to the delivery of immunization [58]. Costs to vaccinate can also exist in the form
of the lost time and cost of transportation, which disproportionately affects low-income
parents, required to vaccine [14]. These results also suggests that teens who lived above
poverty but less than $75,000 may not have qualified for government funded healthcare
and benefits though they were also not financially stable enough to afford the vaccine.
Further research should investigate the association between household income and
influenza vaccination, as well as assess the expense to receive vaccines, including lost
time and transportation costs, for families.
Health Insurance Status
Results from this analysis revealed that after adjusting for other variables, having one
or more form of health insurance was a statistically significant predictor for receipt of
influenza vaccine. These results support the hypothesis that an important barrier to
preventive health services such as influenza vaccination is the lack of access to care.
Most health insurance plans cover the costs of vaccination and the federal government
provides free vaccines through the Vaccines for Children (VFC) program [56]. However,
similar to the findings from the poverty status variable, there remains a population of
children and young adults who may neither be covered by health insurance nor eligible to
receive free VFC vaccines. Approximately 11% of young children and 21% of
adolescents fall outside the care of private health insurance and government programs
[56]. In addition, even with the assistance of the VFC program, families may need to pay
a moderate VFC administrative fee in order to receive the vaccine [58]. It should be
noted, however, that health insurance status was not available on approximately 20% of
the study population and further research is needed in order to better address the
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association between health insurance and influenza vaccination. Evaluation of the type of
health insurance (private, public, military etc,) and if the teen’s insurance had covered the
cost of the vaccine are also important components to consider.
Household-reported Health Status
Asthma
Results from the analysis revealed that having asthma was a statistically
significant predictor for receipt of influenza vaccination. Individuals with asthma are at
increased risk of complications from influenza infection, and the vaccination of adults
and children with asthma has been recommended for many years [41]. These findings are
consistent with previous research which has discussed the association between asthma
status and influenza vaccine status. These findings may reflect better knowledge of
vaccination recommendations or they also may reflect having access to care and
providers who would remind the families about vaccinations [17]. It is important to note
that the percentage of asthmatic teens who receive the influenza vaccine can still be
improved. Healthy People 2010 National Objectives aimed for influenza vaccination of at
least 60% of adults aged 18-64 with asthma and other underlying health conditions, but
studies have shown that vaccination coverage among adults with asthma is low [41].
Although the teens in this study were not part of that particular Healthy People 2010
objective’s age group or risk group, it is important for both public health professionals
and health care providers to keep in mind when developing intervention strategies that
adolescents will soon enter that recommended age-risk group, and that perhaps
intervention targeting adolescents or even younger children may help with vaccination
coverage for reaching Healthy People 2020 objectives. Further research should seek to
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survey the role of physician recommendations, recall/reminder systems, and influenza
vaccination in the asthmatic teen population. The severity of asthma in teens should also
be assessed as one study has suggested low vaccination rates might be attributed to
providers who may not remember to vaccinate patients with milder asthma against
influenza [17].
Underlying Health Conditions
Results from the analysis revealed that having been told by a health professional
that he or she had one of the underlying health conditions surveyed was a statistically
significant predictor for receipt of influenza vaccination. Similar to findings of the
asthma status, these findings may reflect better knowledge of vaccination
recommendations or they also may reflect already requiring or having access to care [17].
It is also possible that teens who reported having underlying health conditions were under
the care of medical specialists or enrolled in health care maintenance organizations with
successful immunization strategies which remind teens and their families with
vaccination updates. For example, one study has found that diagnosis-based billing data
accurately identified children who had high risk health conditions and needed annual
influenza vaccination, and registry-driven reminders/calls significantly increased
influenza immunization in targeted children [59]. The NIS-Teen only assessed whether
the teen had underlying health conditions but did not ask respondents to identify the
specific health conditions. Further research should seek to identify which specific health
conditions (lung diseases versus heart conditions) are more likely to be strong predictors
for receipt of influenza vaccine. The availability of any vaccine recall/reminder program
in place should also be assessed.

46

Number of Missed School Days Due to Illness or Injury
Results from the analysis revealed all subcategories of number of missed school
days, except for 1-9 days, were statistically significant predictors for receipt of influenza
vaccination in this study population. Teens who missed thirty of more school days were
the most likely to receive the influenza vaccination more school days were more likely to
receive the influenza vaccine when compared with teens who did not miss any days of
school. Although the literature has shown that vaccination can reduce student and teacher
absenteeism, and that that influenza-like illness increases the economic burden among
households with school-aged children and leads to more lost school [60], data on the
number of missed school days due to illness or injury as a predictor for influenza
vaccination is limited. It is possible that the school absenteeism was a proxy for
underlying health condition or that vaccine acceptance was linked with amount of
absenteeism caused by influenza-like illness prior to the survey [61]. However, it is
important to note the survey did not distinguish between illness or injury in the study, and
the proportion of the two categories is unknown. It is also unclear the type or pattern
(consecutive versus intermittent) of the illness the teen reported experiencing and if the
illness reported were attributed any significant underlying health conditions. Perhaps a
more appropriate variable might have assessed the number of missed school days due to
influenza-like illness. Further research is needed to better understand the association
between the number of missed school days and influenza vaccination.
Maternal Socio-demographic Characteristics
Mother’s Age
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Results from this analysis revealed that maternal age was a statistically significant
predictor for receipt of influenza vaccination in this study population. Teens who had
mothers in the 35 to 44 and 45 and older age groups were less likely to receive the
influenza vaccine compared with the referent 34 and younger age group. Previous studies
have revealed mixed findings for the association between maternal age and immunization
[62]. Some studies have indicated that children of younger mothers are at increased risk
of underimmunization while other studies have shown no association [62]. One study,
however, has shown that maternal age was an important facto associated with up-to-date
vaccination coverage of children 19-35 months of age in the U.S. for children born to
mothers age 26 and younger [62]. One possibility for the findings in this study is that
mothers in the older age groups were adolescents themselves during the 1976 swine
influenza epidemic and may have recall the increased frequency of Guillain-Barré
Syndrome associated with the vaccine [13]. A parent’s personal experiences with the
influenza vaccination could certainly have shaped their attitudes about vaccination for the
adolescents in this study. Another possibility is that an older mother may indicate the
possibility of the mother having more children in the household. Having additional
children may require additional support and encouragement regarding vaccination [24].
Further studies should assess the association between maternal age, maternal experiences
with vaccination, and receipt of influenza vaccination.
Mother’s Education Level
Although odds ratios from the bivariate analysis suggested that teens who had
mothers who obtained higher levels of education were more likely to receive the
influenza vaccination, results from the multivariate analysis revealed that that maternal
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education level was not a statistically significant predictor for receipt of influenza
vaccination in this study population. Previous studies have shown mixed findings. In one
study, it was found that lower maternal education is associated with undervaccination and
improving the educational status of both parents could potentially improve the
immunization coverage of children [24, 63].Another study has found that children of
mothers who were less educated were more likely to have completed the childhood
4:3:1:3 series [64]. It is also important to recognize that education level also may have
been proxy for socioeconomic status since higher education levels could indicated higher
paying jobs. Additional research in needed to assess the association between maternal
education level and receipt of influenza vaccination.
Mother’s Marital Status
Results from this analysis revealed that after adjusting for other variables,
mother’s marital status was not a statistically significant predictor for receipt of influenza
vaccination. Studies have suggested that those who are separated or divorced suffered the
most negative health outcomes as well were more likely to have children who were
undervaccinated [24, 65]. Although results from this study did not find statistical
significance in mother’s marital status, it is still important for public health practitioners
to recognize that mothers are influential in the vaccination of their children and that
public health interventions should still address maternal concerns and barriers [24].
Further studies should seek to investigate the association of parental marital status,
medical care, and receipt of influenza vaccination.
5.2

Study Limitations
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The results of this study are subject to some limitations. First, this study only
extracted data on influenza vaccination status data from a parent’s or guardian’s recall
based on telephone surveys, and responses from participants may reflect recall bias.
Analysis using only the population with vaccination shot card or verification from
provider was not incorporated for this study. In addition, although mothers are influential
in the vaccination of their children and although a higher percentage of respondents were
mothers, the actual impact of maternal socio-demographic characteristics in this study
population is unknown.
In addition, another component to the recall bias is that the NIS survey was conducted
throughout the calendar year and included three different influenza vaccination seasons
(2006-2007, 2007-2008 and 2008-2009 seasons). The influenza vaccine is administered
annually in a fairly limited time period, and it is possible that respondents who were
surveyed closer to the influenza season were more likely to recall the status of the teen’s
immunization status. Also, because ACIP recommendation to vaccinate children ages 518 had not been included until the 2008-2009 influenza season [66], there could have
been differences in the response of households between the different seasons, but the
impact of the changes in recommendation to providers and parents was not assessed.
Secondly, although the data on type, place, and month of influenza vaccination can be
important in assessing trends, the reason for the large portion of missing data in this study
population is unknown. Lastly, because the NIS is a telephone survey, vaccination,
demographic, and socioeconomic data on households that strictly use cellular telephones
would not have been captured.
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Another limitation is the design of the study itself. Although associations of many
socio-demographic characteristics and household-reported health status with influenza
vaccine receipt could be assessed, the cross-sectional design of the study was not strong
enough to enable an analysis of direct causation for these variables and vaccine
prevalence. Second, unlike other vaccines (HPV, MMR, etc) surveyed in the NIS, the
reasons for decline of receipt of the influenza vaccine were not assessed. The reason for
not incorporating a “reasons for decline of receipt” section in the survey is unknown.
Although health insurance status was found to be a significant predictor, a large
percentage of data on health insurance status was not available either due to unknown or
non-response. Questions from the health insurance status section were addresses towards
the end of the interview, and some respondents who did not complete the demographic
section earlier in the survey did not reach the health insurance questions. The NIS
researchers also addressed the possibility that respondents who began the health
insurance questions may have broke off the interview prior to concluding the survey. It is
also unknown whether the teen’s health insurance covered the entire or a portion of the
cost of receiving the vaccine.
The household-reported health status variables also present a limitation. The data
collected on asthma status and underlying health conditions were self-reported and
responses were not verified by licensed health professionals or the teen’s health care
providers. Also, the data collected on number of missed school days due to illness or
injury was not verified by school officials. Respondents may have reported the teen as
having an underlying health condition when in fact he or she may have a medical issue
not known to put them at high risk for influenza complication. Therefore, errors due to
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both recall and information bias were both possible and unavoidable. As mentioned
earlier, the number of missed school days did not distinguish between illness or injury
and the proportion of the two components is unknown. It is quite possible those who
reported a significant number of missed school days were mainly attributed to extensive
injuries.
5.3 Recommendations
Additional research is needed to address the limitations mentioned above.
Additional studies should evaluate the population with shot cards, include questions
which directly assess the reasons for or against influenza vaccination, and questions
which survey provider recommendations and parental knowledge of influenza vaccines.
A follow-up study on the population with vaccination shot cards and provider
verification should be considered. Verification of vaccination status from primary care
providers or health departments would help reduce the recall bias but would also confirm
other important factors related to influenza vaccination such as place and time of
vaccination. Verification of underlying health condition by the health a health care
provider not only could also help reduce recall bias, but also would help improve our
understanding of the adolescent population who is at high-risk for influenza vaccination.
The NIS surveyed reasons for the decline of the receipt of the meningitis, Human
Papillomavirus, and tetanus vaccines. These included not believing in vaccines, costs,
safety concerns, and lack of knowledge, etc. and should also be addressed with the
influenza vaccine. The fear of needles or injection has been also cited as a reason for
declining receipt of influenza vaccination and should be considered in future
research[39]. It is also unknown the population of teens who declined of the receipt of the
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influenza vaccine due to contraindication. Additional investigation should also seek
reasons for the large amount of data on type, month, and place of influenza vaccine was
not collected. It may also help to survey those who did receive the influenza vaccination
and determine reasons the teens and families pursued receipt of influenza vaccination.
Additional research which assesses reasons for or against influenza vaccination in
combination with socio-demographic characteristics and health status would assist public
health professionals and medical professional in recognizing both strategies to enhance
vaccination as well as areas for improvement in vaccination coverage.
Another important aspect to socio-demographic characteristics would be the
actual costs, time, and transportation needs in order to access preventative health services
and vaccination. Assessing the distance and availability of facilities which offer health
care services would also be helpful. Although VFC and many health insurance policies
cover the costs of vaccinations, the survey does not capture whether parental
inconvenience was a barrier to vaccination in this study population. Children of parents
of low-income working families may be especially vulnerable to under-vaccination or
lack of vaccination as it is often the parents who must take the time to schedule medical
appointments, drive their children to the clinic or hospital in order to receive the vaccines,
and follow-up with any post-vaccination adverse events.
The survey also did not assess whether providers recommended the vaccine to the
teen. Previous studies have shown that recommendations from primary care providers
increased childhood influenza vaccination rates [47]. Health care providers may not be
vaccinated for influenza themselves and may not proactively recommend the influenza
vaccine [14]. Recall or reminder systems established by the provider could also be
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considered a form of recommendation from health care providers. Although assessing
recommendations by health care providers would not include families who do not have
access to care, additional research on whether health care providers recommend the
vaccine in combination with socio-demographic characteristics should still highlight
opportunities to enhance vaccination education to both parents and health care providers.
Finally, another unfortunate known barrier to influenza vaccination is the belief
by parents that the vaccine causes the disease [47]. Parental knowledge of the types of
vaccination available (shot versus mist), when to obtain the vaccination, and the benefits
and risks of influenza vaccination should be assessed. Parental knowledge and
perceptions that obtaining the influenza vaccine is beneficial increases childhood
influenza vaccination rates[47]. The limited data collected on influenza vaccine type, the
month and place the vaccine was administered highlights opportunities to assess
important trend in influenza vaccination and identify gaps in parental knowledge.
5.4 Conclusion
The 2009 H1N1 virus caused the first influenza pandemic since 1968, and
contrary to what had been predicted, North America, not Southeast Asia was the
epicenter of the pandemic. This highlights the need for pandemic response preparedness
by public health professionals, health care providers, media, policy makers, as well as the
general public. Ensuring an adequate vaccination supply and providing updated
vaccination recommendations should also be a priority in preparing for both influenza
epidemics and pandemics. Although influenza-associated pediatric mortality is rare, the
disease still contributes to relatively high rates of emergency department visits, outpatient
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visits, and hospitalizations [11, 67]. Influenza vaccination rates among both healthy
adolescents and adolescents with underlying health condition are still low.
Given the findings of significant associations between socio-demographic
characteristics and household-reported health status in this study and that adolescents are
the next generation of parents, further research needs to consider adolescent sociodemographic factors as a determinant when surveying immunization coverage against
influenza. Although the current influenza vaccine recommendations now include all
individuals ages 6 months and older, it should still be important to recognize and reduce
health disparities and inequalities which contribute to non-vaccination or undervaccination. Improved understanding of demographic and socioeconomic characteristics,
as well as existing underlying health conditions, will facilitate the path to improving
interventions, vaccination rates, and subsequent reduction in the burden of disease.
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